PIK3CB and bladder transitional cell carcinoma: In a recently published study, the authors achieved PI3Kβ depletion by intra-tumoral injection of PIK3CB siRNA, which induced apoptosis and triggered regression of PTEN-mutant tumors even more efficiently than PI3Kβ inhibition in urothelial bladder carcinoma [43].